Syncom Formulations (India) Ltd.
Snapshot View

View in App

Prices View details >>

7.35 -0.05 ▼-0.7%

08 February 2023, 09:54:53 AM
Volume: 137,932

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sfil.in
Market Cap 692.78 Cr.
Enterprise Value(EV) 779.94 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.17 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 42.67 Trailing Twelve Months Ending 2022-09
Industry PE 32.80 Trailing Twelve Months Ending 2022-09
Book Value / Share 2.57 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.87 Calculated using Price: 7.37
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 94.00 Cr. 940,000,000 Shares
FaceValue 1
Company Profile
Syncom Formulations (India) Ltd was originally incorporated as Syncom Formulations (India) Private Limited in the state of Maharashtra on June 21, 1988 under the Companies Act, 1956. Further the status of company was changed to public limited company and thereby name of company changed to Syncom Formulations (India) Limited and a fresh certificate of change of name obtained on July 9, 1992.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.68%
1 Week
-5.16%
1 Month
-16.95%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.19 9.99 9.91 9.56 7.33 8.71 10.24 18.04 10.02
Return on Capital Employed (%) 15.29 15.55 14.72 13.58 9.43 9.37 12.39 20.72 10.61
Return on Assets (%) 6.95 6.82 6.41 5.93 4.90 6.34 7.92 12.27 6.60

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 95 100 109 114 122 133 146 188 222 242
Non Curr. Liab. 7 6 6 8 9 8 7 7 8 9
Curr. Liab. 42 37 66 56 43 36 31 97 78 126
Minority Int.
Equity & Liab. 144 143 181 179 174 176 184 292 308 377
Non Curr. Assets 66 59 89 92 93 95 95 102 168 193
Curr. Assets 78 83 92 87 81 81 89 190 140 184
Misc. Exp. not W/O
Total Assets 144 143 181 179 174 176 184 292 308 377

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 151 173 184 185 159 187 206 245 220 221
Other Income 1 2 3 3 4 5 5 7 12 14
Total Income 152 175 187 188 163 192 211 252 232 235
Total Expenditure -135 -155 -167 -168 -147 -175 -189 -207 -200 -207
PBIDT 17 20 19 19 16 17 22 45 32 28
Interest 0 0 0 0 0 0 -1 0 -2 -2
Depreciation -3 -3 -3 -3 -4 -4 -4 -4 -4 -4
Taxation -5 -6 -6 -5 -3 -2 -3 -12 -6 -6
Exceptional Items -1 0 0 0 0 0 0 0
PAT 9 10 10 11 9 11 14 29 20 16
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 6 7 0 24 17 -2 4 6 -2 16
Cash Fr. Inv. 0 -4 1 -23 -8 -2 2 2 -75 -27
Cash Fr. Finan. -6 -1 1 -2 -2 -2 0 -7 72 8
Net Change -1 2 2 -1 6 -6 7 1 -5 -2
Cash & Cash Eqvt 4 5 7 6 7 1 7 8 3 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 40.48 41.18 41.18 44.01 44.01 46.12 50.57 50.57 50.57
Public 59.52 58.82 58.82 55.99 55.99 53.88 49.43 49.43 49.43
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 03 Feb 2023
Board Meeting Intimation
SYNCOM FORMULATIONS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2023 to consider financial statements for the period ended December 2022, Financial results/Other business.
Thu, 02 Feb 2023
Board Meeting Intimation
SYNCOM FORMULATIONS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2023 to consider financial statements for the period ended December 2022, Financial results/Other business.
Fri, 20 Jan 2023
Updates
Syncom Formulations (India) Limited has informed the Exchange regarding 'Syncom Formulations (India) Limited has informed the Exchange about the SDD Certificate for the Quarter ended 31st December,2022. '.

Technical Scans View Details >>

Tue, 07 Feb 2023
Higher Delivery Quantity Higher Delivery Quantity
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
CCI Oversold Zone CCI Oversold Zone
RSI Oversold Zone RSI Oversold Zone

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,002.25 -0.4%
Cipla Ltd. 83,244.79 1,026.35 -0.5%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,452.85 +0.3%
Divi's Laboratories Ltd. 72,982.62 2,778.20 +1.0%
Apollo Hospitals Enterprise Ltd. 62,084.06 4,330.00 +0.3%
Torrent Pharmaceuticals Ltd. 51,953.07 1,538.90 +0.2%
Zydus Lifesciences Ltd. 48,525.07 476.65 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,002.25 -0.4%
Cipla Ltd. Consolidated 2022-12 31.56 1,026.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,452.85 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,778.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,330.00 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,538.90 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 476.65 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,002.25 -0.4%
Cipla Ltd. Consolidated 2022-12 3.67 1,026.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,452.85 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,778.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,330.00 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,538.90 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 476.65 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,002.25 -0.4%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,452.85 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,778.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,330.00 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,538.90 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 476.65 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,002.25 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,452.85 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,778.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,330.00 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.90 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 476.65 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,002.25 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,452.85 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,778.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,330.00 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.90 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 476.65 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,002.25 -0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,452.85 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,778.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,330.00 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,538.90 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 476.65 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,002.25 -0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.35 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,452.85 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,778.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,330.00 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,538.90 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 476.65 -0.6%

FAQ's On Syncom Formulations (India) Ltd.

What is Syncom Formulations share price?
Can I buy Syncom Formulations shares now?
What is the Market Cap of Syncom Formulations?
What are the key metrics to analyse Syncom Formulations?
What is the 52 Week High and Low of Syncom Formulations?
What is the trend of Syncom Formulations share price?